HomeCompareKDGTF vs EQR

KDGTF vs EQR: Dividend Comparison 2026

KDGTF yields 292.70% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KDGTF wins by $1283.49M in total portfolio value
10 years
KDGTF
KDGTF
● Live price
292.70%
Share price
$0.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1283.54M
Annual income
$767,632,391.00
Full KDGTF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — KDGTF vs EQR

📍 KDGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDGTFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDGTF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDGTF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDGTF
Annual income on $10K today (after 15% tax)
$24,879.26/yr
After 10yr DRIP, annual income (after tax)
$652,487,532.35/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, KDGTF beats the other by $652,482,878.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDGTF + EQR for your $10,000?

KDGTF: 50%EQR: 50%
100% EQR50/50100% KDGTF
Portfolio after 10yr
$641.79M
Annual income
$383,818,933.30/yr
Blended yield
59.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

KDGTF
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDGTF buys
0
EQR buys
0
No recent congressional trades found for KDGTF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDGTFEQR
Forward yield292.70%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1283.54M$47.8K
Annual income after 10y$767,632,391.00$5,475.61
Total dividends collected$1231.38M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KDGTF vs EQR ($10,000, DRIP)

YearKDGTF PortfolioKDGTF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$39,970$29,269.72$11,380$679.82+$28.6KKDGTF
2$152,104$109,336.69$13,014$837.25+$139.1KKDGTF
3$551,611$388,859.29$14,961$1,036.20+$536.6KKDGTF
4$1,908,177$1,317,953.42$17,297$1,289.22+$1.89MKDGTF
5$6,302,657$4,260,907.77$20,121$1,613.15+$6.28MKDGTF
6$19,896,799$13,152,956.21$23,561$2,030.84+$19.87MKDGTF
7$60,095,598$38,806,022.48$27,783$2,573.54+$60.07MKDGTF
8$173,842,808$109,540,518.26$33,013$3,284.39+$173.81MKDGTF
9$482,157,266$296,145,461.77$39,547$4,223.51+$482.12MKDGTF
10$1,283,540,666$767,632,391.00$47,791$5,475.61+$1283.49MKDGTF

KDGTF vs EQR: Complete Analysis 2026

KDGTFStock

Kindstar Globalgene Technology, Inc. provides esoteric testing services to hospitals in China. The company offers its esoteric testing services for clinical specialist physicians in hematologic tumor, rare diseases, diseases of obstetrics and gynecology, neurology, infectious diseases, solid tumors, etc. It provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and other esoteric testing laboratories. The company was founded in 2003 and is headquartered in in Wuhan, China.

Full KDGTF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this KDGTF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDGTF vs SCHDKDGTF vs JEPIKDGTF vs OKDGTF vs KOKDGTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.